Literature DB >> 10935273

Newcastle disease and other avian paramyxoviruses.

D J Alexander1.   

Abstract

Newcastle disease (ND), caused by avian paramyxovirus serotype 1 (APMV-1) viruses, is included in List A of the Office International des Epizooties. Historically, ND has been a devastating disease of poultry, and in many countries the disease remains one of the major problems affecting existing or developing poultry industries. Even in countries where ND may be considered to be controlled, an economic burden is still associated with vaccination and/or maintaining strict biosecurity measures. The variable nature of Newcastle disease virus strains in terms of virulence for poultry and the different susceptibilities of the different species of birds mean that for control and trade purposes, ND requires careful definition. Confirmatory diagnosis of ND requires the isolation and characterisation of the virus involved. Assessments of virulence conventionally require in vivo testing. However, in vitro genetic characterisation of viruses is being used increasingly now that the molecular basis of pathogenicity is more fully understood. Control of ND is by prevention of introduction and spread, good biosecurity practices and/or vaccination. Newcastle disease viruses may infect humans, usually causing transient conjunctivitis, but human-to-human spread has never been reported. Eight other serotypes of avian paramyxoviruses are recognised, namely: APMV-2 to APMV-9. Most of these serotypes appear to be present in natural reservoirs of specific feral avian species, although other host species are usually susceptible. Only APMV-2 and APMV-3 viruses have made a significant disease and economic impact on poultry production. Both types of viruses cause respiratory disease and egg production losses which may be severe when exacerbated by other infections or environmental stresses. No reports exist of natural infections of chickens with APMV-3 viruses.

Entities:  

Mesh:

Year:  2000        PMID: 10935273     DOI: 10.20506/rst.19.2.1231

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  154 in total

1.  Efficacy of thermostable I-2 Newcastle disease vaccine compared to B1 commercial vaccine in broiler chicken.

Authors:  A H Asl Najjari; H Nili; K Asasi; N Mosleh; H Rohollahzadeh; S Mokhayeri
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

2.  Detection of specific antigens of Newcastle disease virus using an absorbed Western blotting method.

Authors:  F Hemmatzadeh; M Kazemimanesh
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

3.  Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.

Authors:  Wenbin Wang; Xudong Chang; Wei Yao; Ning Wei; Na Huo; Yanhong Wang; Qiaolin Wei; Haijin Liu; Xinglong Wang; Shuxia Zhang; Zengqi Yang; Sa Xiao
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

4.  Autophagy benefits the replication of Newcastle disease virus in chicken cells and tissues.

Authors:  Yingjie Sun; Shengqing Yu; Na Ding; Chunchun Meng; Songshu Meng; Shilei Zhang; Yuan Zhan; Xusheng Qiu; Lei Tan; Hongjun Chen; Cuiping Song; Chan Ding
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

Review 5.  Multi-Scale Airborne Infectious Disease Transmission.

Authors:  Charles F Dillon; Michael B Dillon
Journal:  Appl Environ Microbiol       Date:  2020-12-04       Impact factor: 4.792

6.  Site-specific glycosylation of the Newcastle disease virus haemagglutinin-neuraminidase.

Authors:  Cassandra L Pegg; Christine Hoogland; Jeffrey J Gorman
Journal:  Glycoconj J       Date:  2016-12-07       Impact factor: 2.916

7.  Complete genome sequence of highly virulent neurotropic Newcastle disease virus strain Texas GB.

Authors:  Anandan Paldurai; Sachin Kumar; Baibaswata Nayak; Siba K Samal
Journal:  Virus Genes       Date:  2010-04-30       Impact factor: 2.332

8.  Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.

Authors:  Oscar Antonio Ortega-Rivera; J Luis Quintanar; Susana Del Toro-Arreola; Ángel G Alpuche-Solis; Mayra J Esparza-Araiza; Eva Salinas
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

9.  Phylogenetic and pathotypic characterization of newcastle disease viruses circulating in west Africa and efficacy of a current vaccine.

Authors:  Arthur Samuel; Baibaswata Nayak; Anandan Paldurai; Sa Xiao; Gilbert L Aplogan; Kodzo A Awoume; Richard J Webby; Mariette F Ducatez; Peter L Collins; Siba K Samal
Journal:  J Clin Microbiol       Date:  2012-12-19       Impact factor: 5.948

10.  Surveillance and molecular characterization of Newcastle disease virus in seafowl from coastal areas of China in 2011.

Authors:  Xiaoyuan Yuan; Youling Wang; Jun Li; Kexiang Yu; Jinxing Yang; Huaiying Xu; Yuxia Zhang; Hongbin Ai; Jinbao Wang
Journal:  Virus Genes       Date:  2012-12-18       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.